Drug Delivery Interfaces in the 21st Century: From Science Fiction Ideas to Viable Technologies

被引:65
作者
Chertok, Beata [1 ,2 ]
Webber, Matthew J. [2 ,3 ]
Succi, Marc D. [2 ,4 ,5 ]
Langer, Robert [1 ,2 ]
机构
[1] MIT, Dept Chem Engn, Cambridge, MA 02139 USA
[2] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA
[3] Boston Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
[5] Brigham & Womens Hosp, Boston, MA 02115 USA
关键词
drug delivery; drug carriers; nanotechnology; controlled release implants; physiological barriers; pharmacokinetics; translational medicine; PEGYLATED LIPOSOMAL DOXORUBICIN; INTENSITY FOCUSED ULTRASOUND; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; POLYETHYLENE-GLYCOL; MALIGNANT GLIOMA; BLOOD-CELLS; PHARMACOKINETICS; INSULIN; FLOW;
D O I
10.1021/mp4003283
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Early science fiction envisioned the future of drug delivery as targeted micrometer-scale submarines and "cyborg" body parts. Here we describe the progression of the field toward technologies that are now beginning to capture aspects of this early vision. Specifically, we focus on the two most prominent types of systems in drug delivery: the intravascular micro/nano drug carriers for delivery to the site of pathology and drug-loaded implantable devices that facilitate release with the predefined kinetics or in response to a specific cue. We discuss the unmet clinical needs that inspire these designs, the physiological factors that pose difficult challenges for their realization, and viable technologies that promise robust solutions. We also offer a perspective on where drug delivery may be in the next 50 years based on expected advances in material engineering and in the context of future diagnostics.
引用
收藏
页码:3531 / 3543
页数:13
相关论文
共 119 条
[1]   Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy [J].
Aggarwal, Parag ;
Hall, Jennifer B. ;
McLeland, Christopher B. ;
Dobrovolskaia, Marina A. ;
McNeil, Scott E. .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (06) :428-437
[2]  
AMIDON GL, 1994, ANNU REV PHARMACOL, V34, P321
[3]   Materials science - Smart biomaterials [J].
Anderson, DG ;
Burdick, JA ;
Langer, R .
SCIENCE, 2004, 305 (5692) :1923-1924
[4]   Foreign body reaction to biomaterials [J].
Anderson, James M. ;
Rodriguez, Analiz ;
Chang, David T. .
SEMINARS IN IMMUNOLOGY, 2008, 20 (02) :86-100
[5]  
[Anonymous], 2011 NAT DIAB FACT S
[6]  
[Anonymous], 2013, CANC FACTS FIG 2013
[7]   Mechanisms for the bone anabolic effect of parathyroid hormone treatment in humans [J].
Aslan, Derya ;
Andersen, Mille Dahl ;
Gede, Lene Bjerring ;
de Franca, Tine Kellemann ;
Jorgensen, Sara Rubek ;
Schwarz, Peter ;
Jorgensen, Niklas Rye .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2012, 72 (01) :14-22
[8]   Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience [J].
Attenello, Frank J. ;
Mukherjee, Debraj ;
Datoo, Ghazala ;
McGirt, Matthew J. ;
Bohan, Eileen ;
Weingart, Jon D. ;
Olivi, Alessandro ;
Quinones-Hinojosa, Alfredo ;
Brem, Henry .
ANNALS OF SURGICAL ONCOLOGY, 2008, 15 (10) :2887-2893
[9]   CEPHALIC PHASE OF INSULIN-SECRETION AND FOOD STIMULATION IN HUMANS - A NEW PERSPECTIVE [J].
BELLISLE, F ;
LOUISSYLVESTRE, J ;
DEMOZAY, F ;
BLAZY, D ;
LEMAGNEN, J .
AMERICAN JOURNAL OF PHYSIOLOGY, 1985, 249 (06) :E639-E645
[10]   Materials for Diabetes Therapeutics [J].
Bratlie, Kaitlin M. ;
York, Roger L. ;
Invernale, Michael A. ;
Langer, Robert ;
Anderson, Daniel G. .
ADVANCED HEALTHCARE MATERIALS, 2012, 1 (03) :267-284